DIRECT-TO-CONSUMER Rx DRUG ADVERTISING DOES NOT NECESSARILY IMPLY HIGHER PRICES AND COULD LEAD TO DECREASES, FTC ECONOMIST TELLS DIA ANNUAL MEETING